Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics.
Int J Pharm. 2023 Oct 15;645:123384. doi: 10.1016/j.ijpharm.2023.123384. Epub 2023 Sep 8.
Int J Pharm. 2023.
PMID: 37678472
Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer.
Parupathi P, Campanelli G, Deabel RA, Puaar A, Devarakonda LS, Kumar A, Levenson AS.
Parupathi P, et al.
Cancers (Basel). 2022 Dec 8;14(24):6038. doi: 10.3390/cancers14246038.
Cancers (Basel). 2022.
PMID: 36551523
Free PMC article.
Item in Clipboard
The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer.
Campanelli G, Francois E, Parupathi P, Devarakonda LS, Yang C, Kumar A, Levenson AS.
Campanelli G, et al. Among authors: parupathi p.
Cancers (Basel). 2024 Mar 29;16(7):1344. doi: 10.3390/cancers16071344.
Cancers (Basel). 2024.
PMID: 38611022
Free PMC article.
Item in Clipboard
Molecular Efficacy of Gnetin C as Dual-Targeted Therapy for Castrate-Resistant Prostate Cancer.
Campanelli G, Deabel RA, Puaar A, Devarakonda LS, Parupathi P, Zhang J, Waxner N, Yang C, Kumar A, Levenson AS.
Campanelli G, et al. Among authors: parupathi p.
Mol Nutr Food Res. 2023 Dec;67(24):e2300479. doi: 10.1002/mnfr.202300479. Epub 2023 Oct 20.
Mol Nutr Food Res. 2023.
PMID: 37863824
Item in Clipboard
Cite
Cite